Delivery Order SPE2DB22D2218-SPE2DB25FR3FD
Award Date 8/19/25
Potential Completion Date 9/10/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $4,687.18 for Tezspire 210 mg/1.91 mL pens, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete successfully in open federal procurement...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tezspire 210 mg/1.91 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a child contract with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is part of AmerisourceBergen's broader engagement with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen on August 27, 2025, with a completion date of September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be supplied to the...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pens on August 21, 2025, with completion targeted for September 12, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitively awarded delivery order for a specialty pharmaceutical product to support federal medical procurement needs. The award was issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a $4,687.18 firm fixed-price delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injections. The contract represents a non-set-aside, competitively awarded delivery order with a completion deadline of September 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 ml pen injectors. This firm fixed price, competitively awarded contract is scheduled for completion by June 27, 2025, with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers. This...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injectables, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract structure with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This firm fixed-price delivery order, valued at $9,374.36, is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the company's proven...
- The Defense Logistics Agency awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with a completion date of May 15, 2025. This is a firm fixed price, non-set-aside competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...